Key result
NDAT-V8 outperforms NDAT-V6 and RWPT as a non-invasive surrogate for LV posterolateral wall delay during LBBAP.
Why the study?
Does NDAT-V8 provide a reliable non-invasive surrogate for LV posterolateral wall delay during left bundle branch area pacing in patients undergoing LOT-CRT?
Comparison
NDAT-V8 vs NDAT-V6 and RWPT in V6 and V8
Authors
Loading...
NDAT-V8 may enhance LBBAP resynchronization guidance; hypothesis-generating and requires prospective trials before routine adoption.
Observational (n=30)
Does NDAT-V8 provide a reliable non-invasive surrogate for LV posterolateral wall delay during left bundle branch area pacing in patients undergoing LOT-CRT?
Effect estimate: r = 0.922
NDAT-V8 is a reliable non-invasive surrogate for LV posterolateral wall delay during left bundle branch area pacing, outperforming standard V6 measurements.
Ramalingam et al. (2026) conducted an observational in Patients undergoing LOT-CRT implantation (n=30). Lead V8 negative derivative activation time (NDAT-V8) vs. NDAT-V6 and R-wave peak time (RWPT) in V6 and V8 was evaluated on Correlation with left ventricular electrical delay (LVED) during intrinsic conduction and LBBAP pacing subtypes (r = 0.922). The negative derivative activation time in lead V8 (NDAT-V8) strongly correlated with left ventricular electrical delay during left bundle branch area pacing (combined r=0.922), outperforming V6.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: